The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.

Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.

Pfizer Inc. defeated a lawsuit from Texas Attorney General Ken Paxton that alleged the pharmaceutical giant misrepresented ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

A four-year-old video is being used to falsely claim the head of one of the world's major COVID-19 vaccine developers never ...

LUBBOCK, Texas (KCBD) - A lawsuit against Pfizer brought by Attorney General Ken Paxton has been dismissed by a Lubbock ...

Pfizer stock has been weighed down lately, amid falling revenues and margins. The demand for the Covid-19 vaccine has taken a ...

Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase II for Influenzavirus A Infections.

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the ...